PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis

被引：0
|
作者：
Anamika Gupta
Sudhir K. Pal
Divya Pandey
Najneen A. Fakir
Sunita Rathod
Dhiraj Sinha
S. SivaKumar
Pallavi Sinha
Mycal Periera
Shilpa Balgam
Gomathi Sekar
K. R. UmaDevi
Shampa Anupurba
Vijay Nema
机构：
[1] National AIDS Research Institute,Department of Molecular Biology
[2] National Institute for Research in Tuberculosis,Department of Microbiology, Institute of Medical Sciences
[3] Banaras Hindu University,Department of Microbiology and Clinical Pathology
[4] National AIDS Research Institute,Department of Bioinformatics, IIDS, Nehru Science Center
[5] Intermediate Reference Laboratory State TB Training and Demonstration Centre (STDC) Pune,undefined
[6] University of Allahabad,undefined
来源：
Annals of Clinical Microbiology and Antimicrobials | / 16卷
关键词：
PknB; Conservation; Multidrug resistant; Mutation; Sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 39 条
  • [21] Synthesis of novel isoniazid incorporated styryl quinazolinones as anti-tubercular agents against INH sensitive and MDR M. tuberculosis strains
    Reddy Raghunath Babu
    K. Naresh
    Alvala Ravi
    B. Madhava Reddy
    V. Harinadha Babu
    Medicinal Chemistry Research, 2014, 23 : 4414 - 4419
  • [22] Highly transmitted M. tuberculosis strains are more likely to evolve MDR/XDR and cause outbreaks, but what makes them highly transmitted?
    Emane, Amel Kevin Alame
    Guo, Xujun
    Takiff, Howard E.
    Liu, Shengyuan
    TUBERCULOSIS, 2021, 129
  • [23] In Silico Drug Target Discovery Through Proteome Mining from M. tuberculosis: An Insight into Antivirulent Therapy
    Bhattacharya, Shreya
    Ghosh, Puja
    Banerjee, Debasmita
    Banerjee, Arundhati
    Ray, Sujay
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2020, 23 (03) : 253 - 268
  • [24] THE POSSIBLE DEVELOPMENT OF RESISTANT STRAINS OF M. TUBERCULOSIS DURING THE TREATMENT OF TUBERCULOUS MENINGITIS WITH ISONICOTINIC ACID HYDRAZIDE
    GROLLKAHL, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1956, 81 (30) : 1202 - 1204
  • [25] Whole Genome Sequencing M. Tuberculosis Strains In Kwazulu-Natal Reveals Multiple Lineages And Extensive Diversity Of Mdr And Xdr-Tb
    Cohen, K. A.
    Earl, A. M.
    Abeel, T.
    Desjardins, C. A.
    Maharaj, K.
    Munsamy, V.
    Govender, P.
    O'Donnell, M. R.
    Padayatchi, N.
    Nordenberg, D.
    Cassell, G. H.
    Bishai, W. R.
    Pym, A. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [26] Molecular Modeling and Docking Studies of O-Succinylbenzoate Synthase of M. tuberculosis—a Potential Target for Antituberculosis Drug Design
    Madhusudana Pulaganti
    Babajan Banaganapalli
    Chaitanya Mulakayala
    Suresh Kumar Chitta
    Anuradha C. M.
    Applied Biochemistry and Biotechnology, 2014, 172 : 1407 - 1432
  • [27] Molecular Modeling and Docking Studies of O-Succinylbenzoate Synthase of M. tuberculosis-a Potential Target for Antituberculosis Drug Design
    Pulaganti, Madhusudana
    Banaganapalli, Babajan
    Mulakayala, Chaitanya
    Chitta, Suresh Kumar
    Anuradha, C. M.
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2014, 172 (03) : 1407 - 1432
  • [28] M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
    Sharma, Divakar
    Bisht, Deepa
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [29] Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study
    Tiwari, Sandeep
    Barh, Debmalya
    Imchen, M.
    Rao, Eswar
    Kumavath, Ranjith K.
    Seenivasan, S. Prabu
    Jaiswal, Arun K.
    Jamal, Syed B.
    Kumar, Vanaja
    Ghosh, Preetam
    Azevedo, Vasco
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (31) : 2731 - 2740
  • [30] Efficacy of treatment of MDR/XDR TB patients based on rapid diagnostics of M. tuberculosis drug resistance by GenoType MTBDRplus and GenoType MTBDRsl (Hain Lifescience GmbH, Germany)
    Vasilyeva, Irina
    Samoilova, Anastasia
    Larionova, Elena
    Smirnova, Tatyana
    Bagdasaryan, Tatevik
    Chernousouva, Larica
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
1234